Tarun Pandey
Concepts (198)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diagnostic Imaging | 7 | 2023 | 184 | 2.400 |
Why?
| Magnetic Resonance Imaging | 13 | 2021 | 1604 | 2.360 |
Why?
| Soft Tissue Neoplasms | 3 | 2020 | 65 | 1.850 |
Why?
| Amyloidosis | 5 | 2016 | 85 | 1.720 |
Why?
| Sarcoma | 3 | 2020 | 73 | 1.500 |
Why?
| Magnetic Resonance Imaging, Cine | 4 | 2016 | 65 | 1.200 |
Why?
| Pelvic Organ Prolapse | 3 | 2021 | 28 | 0.960 |
Why?
| Joint Diseases | 2 | 2014 | 43 | 0.940 |
Why?
| Physical Examination | 2 | 2014 | 99 | 0.930 |
Why?
| Pelvis | 3 | 2020 | 76 | 0.930 |
Why?
| Cardiomyopathies | 2 | 2016 | 129 | 0.900 |
Why?
| Tendons | 1 | 2023 | 32 | 0.900 |
Why?
| Lower Extremity | 1 | 2023 | 103 | 0.850 |
Why?
| Pelvic Floor | 3 | 2021 | 47 | 0.800 |
Why?
| Image Interpretation, Computer-Assisted | 3 | 2016 | 119 | 0.750 |
Why?
| Abdominal Neoplasms | 1 | 2020 | 19 | 0.730 |
Why?
| Pelvic Neoplasms | 1 | 2020 | 20 | 0.730 |
Why?
| Algorithms | 2 | 2014 | 697 | 0.720 |
Why?
| Contrast Media | 3 | 2016 | 221 | 0.700 |
Why?
| Menisci, Tibial | 1 | 2018 | 9 | 0.650 |
Why?
| Cartilage Diseases | 1 | 2018 | 14 | 0.640 |
Why?
| Bone Marrow Transplantation | 2 | 2016 | 149 | 0.640 |
Why?
| Osteoarthritis | 1 | 2018 | 71 | 0.600 |
Why?
| Suburethral Slings | 1 | 2016 | 12 | 0.590 |
Why?
| Surgical Mesh | 1 | 2016 | 18 | 0.580 |
Why?
| Musculoskeletal Diseases | 1 | 2016 | 40 | 0.570 |
Why?
| Urinary Incontinence, Stress | 1 | 2016 | 31 | 0.570 |
Why?
| Gadolinium | 1 | 2016 | 54 | 0.560 |
Why?
| Tomography, X-Ray Computed | 5 | 2017 | 1213 | 0.550 |
Why?
| Stem Cell Transplantation | 1 | 2016 | 196 | 0.500 |
Why?
| Neurofibroma | 1 | 2014 | 16 | 0.500 |
Why?
| Image Enhancement | 2 | 2014 | 56 | 0.500 |
Why?
| Wrist Joint | 1 | 2014 | 11 | 0.490 |
Why?
| Ankle Joint | 1 | 2014 | 28 | 0.480 |
Why?
| Heart Diseases | 1 | 2016 | 237 | 0.470 |
Why?
| Hip Joint | 1 | 2014 | 66 | 0.470 |
Why?
| Elbow Joint | 1 | 2014 | 38 | 0.470 |
Why?
| Myocardium | 2 | 2016 | 441 | 0.460 |
Why?
| Shoulder Joint | 1 | 2014 | 71 | 0.460 |
Why?
| Humans | 31 | 2023 | 54284 | 0.450 |
Why?
| Knee Joint | 1 | 2014 | 177 | 0.430 |
Why?
| Pelvic Pain | 1 | 2010 | 13 | 0.380 |
Why?
| Varicose Veins | 1 | 2010 | 18 | 0.380 |
Why?
| Biopsy | 4 | 2017 | 692 | 0.370 |
Why?
| Ovary | 1 | 2010 | 105 | 0.370 |
Why?
| Magnetic Resonance Angiography | 1 | 2010 | 80 | 0.370 |
Why?
| Abdomen | 2 | 2020 | 83 | 0.350 |
Why?
| Postoperative Complications | 1 | 2016 | 1033 | 0.330 |
Why?
| Finger Injuries | 1 | 2008 | 12 | 0.330 |
Why?
| Tendon Injuries | 1 | 2008 | 20 | 0.330 |
Why?
| Practice Guidelines as Topic | 3 | 2020 | 492 | 0.310 |
Why?
| Fractures, Bone | 1 | 2008 | 119 | 0.300 |
Why?
| Female | 16 | 2021 | 28441 | 0.280 |
Why?
| Middle Aged | 11 | 2018 | 13088 | 0.270 |
Why?
| Predictive Value of Tests | 4 | 2016 | 1048 | 0.250 |
Why?
| Arthralgia | 2 | 2014 | 50 | 0.240 |
Why?
| Chi-Square Distribution | 2 | 2016 | 318 | 0.240 |
Why?
| Male | 14 | 2018 | 27334 | 0.220 |
Why?
| Diagnosis, Differential | 4 | 2016 | 1136 | 0.200 |
Why?
| Pelvic Floor Disorders | 1 | 2021 | 29 | 0.190 |
Why?
| Retrospective Studies | 6 | 2021 | 6432 | 0.170 |
Why?
| Elbow | 1 | 2019 | 24 | 0.170 |
Why?
| Peripheral Nervous System Diseases | 1 | 2018 | 63 | 0.160 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 1693 | 0.150 |
Why?
| Tissue Transplantation | 1 | 2017 | 11 | 0.150 |
Why?
| Time Factors | 2 | 2016 | 3213 | 0.150 |
Why?
| Muscle Neoplasms | 1 | 2017 | 21 | 0.150 |
Why?
| Neurilemmoma | 1 | 2017 | 28 | 0.150 |
Why?
| Treatment Outcome | 5 | 2016 | 5604 | 0.150 |
Why?
| Software | 2 | 2016 | 296 | 0.150 |
Why?
| Bile Duct Diseases | 1 | 2016 | 11 | 0.140 |
Why?
| Radiography | 1 | 2018 | 524 | 0.140 |
Why?
| Hepatic Artery | 1 | 2016 | 25 | 0.140 |
Why?
| Radiographic Image Enhancement | 1 | 2016 | 32 | 0.140 |
Why?
| Gadolinium DTPA | 1 | 2016 | 33 | 0.140 |
Why?
| Thoracic Diseases | 1 | 2016 | 9 | 0.140 |
Why?
| Free Tissue Flaps | 1 | 2017 | 56 | 0.140 |
Why?
| Prognosis | 3 | 2016 | 2118 | 0.140 |
Why?
| Lymphatic Diseases | 1 | 2016 | 24 | 0.140 |
Why?
| Sensitivity and Specificity | 3 | 2013 | 923 | 0.130 |
Why?
| Sarcoidosis | 1 | 2016 | 44 | 0.130 |
Why?
| Ischemia | 1 | 2016 | 177 | 0.130 |
Why?
| Skin | 1 | 2019 | 469 | 0.130 |
Why?
| Positron-Emission Tomography | 2 | 2016 | 322 | 0.130 |
Why?
| Adult | 6 | 2014 | 14207 | 0.130 |
Why?
| Heel | 1 | 2014 | 7 | 0.130 |
Why?
| Odds Ratio | 1 | 2016 | 604 | 0.120 |
Why?
| Speech Recognition Software | 1 | 2014 | 3 | 0.120 |
Why?
| Time Management | 1 | 2014 | 8 | 0.120 |
Why?
| Databases as Topic | 1 | 2014 | 46 | 0.120 |
Why?
| Efficiency | 1 | 2014 | 36 | 0.120 |
Why?
| Electronic Mail | 1 | 2014 | 19 | 0.120 |
Why?
| Radiology Information Systems | 1 | 2014 | 29 | 0.120 |
Why?
| Confidentiality | 1 | 2014 | 37 | 0.120 |
Why?
| Computer Security | 1 | 2014 | 22 | 0.120 |
Why?
| Workload | 1 | 2014 | 52 | 0.120 |
Why?
| Pregnancy, Abdominal | 1 | 2013 | 8 | 0.120 |
Why?
| Systole | 1 | 2014 | 80 | 0.120 |
Why?
| Writing | 1 | 2014 | 42 | 0.120 |
Why?
| Thrombosis | 1 | 2016 | 243 | 0.120 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2013 | 23 | 0.110 |
Why?
| Case-Control Studies | 1 | 2016 | 1228 | 0.110 |
Why?
| Rectum | 1 | 2013 | 51 | 0.110 |
Why?
| Information Dissemination | 1 | 2014 | 104 | 0.110 |
Why?
| Rectal Neoplasms | 1 | 2013 | 51 | 0.110 |
Why?
| Retroperitoneal Neoplasms | 1 | 2012 | 17 | 0.110 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 126 | 0.110 |
Why?
| Radiology | 1 | 2014 | 140 | 0.100 |
Why?
| Early Detection of Cancer | 1 | 2013 | 162 | 0.100 |
Why?
| Takotsubo Cardiomyopathy | 1 | 2012 | 25 | 0.100 |
Why?
| Internet | 1 | 2014 | 275 | 0.100 |
Why?
| Multiple Myeloma | 3 | 2016 | 3035 | 0.100 |
Why?
| Defecography | 2 | 2021 | 16 | 0.100 |
Why?
| Acetylcysteine | 1 | 2011 | 118 | 0.100 |
Why?
| Liver Failure, Acute | 1 | 2011 | 64 | 0.100 |
Why?
| Hepatitis C | 1 | 2012 | 94 | 0.100 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 106 | 0.100 |
Why?
| Ventricular Function, Left | 1 | 2012 | 181 | 0.100 |
Why?
| Ultrasonography | 2 | 2013 | 480 | 0.090 |
Why?
| Phlebography | 1 | 2010 | 70 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 476 | 0.090 |
Why?
| Risk Factors | 2 | 2016 | 3935 | 0.090 |
Why?
| Mass Screening | 1 | 2013 | 370 | 0.090 |
Why?
| Endosonography | 1 | 2010 | 96 | 0.090 |
Why?
| Syndrome | 1 | 2010 | 252 | 0.090 |
Why?
| Embolization, Therapeutic | 1 | 2010 | 98 | 0.090 |
Why?
| Acetaminophen | 1 | 2011 | 349 | 0.080 |
Why?
| Telemedicine | 1 | 2014 | 449 | 0.080 |
Why?
| HIV Infections | 1 | 2012 | 394 | 0.080 |
Why?
| Aged | 4 | 2016 | 10054 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2013 | 642 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2014 | 3431 | 0.070 |
Why?
| Follow-Up Studies | 1 | 2010 | 2387 | 0.060 |
Why?
| Neoplasm Staging | 2 | 2013 | 806 | 0.050 |
Why?
| Brachial Plexus Neuropathies | 1 | 2018 | 10 | 0.040 |
Why?
| Spinal Cord Neoplasms | 1 | 2018 | 15 | 0.040 |
Why?
| Nerve Sheath Neoplasms | 1 | 2018 | 23 | 0.040 |
Why?
| Reproducibility of Results | 2 | 2013 | 1304 | 0.040 |
Why?
| Patient Care Planning | 1 | 2018 | 79 | 0.040 |
Why?
| Neurosurgical Procedures | 1 | 2018 | 120 | 0.040 |
Why?
| Myoblasts, Skeletal | 1 | 2017 | 11 | 0.040 |
Why?
| Fibula | 1 | 2017 | 23 | 0.040 |
Why?
| Radiotherapy, Adjuvant | 1 | 2017 | 66 | 0.040 |
Why?
| Soft Tissue Injuries | 1 | 2017 | 22 | 0.040 |
Why?
| Tibial Fractures | 1 | 2017 | 34 | 0.040 |
Why?
| Biliary Tract Surgical Procedures | 1 | 2016 | 11 | 0.040 |
Why?
| Constriction, Pathologic | 1 | 2016 | 104 | 0.040 |
Why?
| Endoscopy, Digestive System | 1 | 2016 | 53 | 0.040 |
Why?
| Angiography | 1 | 2016 | 147 | 0.030 |
Why?
| Cell Transformation, Neoplastic | 1 | 2017 | 200 | 0.030 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 87 | 0.030 |
Why?
| Biopsy, Needle | 1 | 2016 | 195 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 259 | 0.030 |
Why?
| Hepatitis C, Chronic | 1 | 2016 | 89 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2016 | 431 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2016 | 514 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 281 | 0.030 |
Why?
| Delegation, Professional | 1 | 2014 | 1 | 0.030 |
Why?
| Online Systems | 1 | 2014 | 9 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 643 | 0.030 |
Why?
| Search Engine | 1 | 2014 | 8 | 0.030 |
Why?
| Liver Transplantation | 1 | 2016 | 160 | 0.030 |
Why?
| Survival Analysis | 1 | 2016 | 735 | 0.030 |
Why?
| Cell Differentiation | 1 | 2017 | 720 | 0.030 |
Why?
| Efficiency, Organizational | 1 | 2014 | 53 | 0.030 |
Why?
| Information Storage and Retrieval | 1 | 2014 | 64 | 0.030 |
Why?
| False Positive Reactions | 1 | 2013 | 68 | 0.030 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2014 | 61 | 0.030 |
Why?
| Echocardiography | 1 | 2016 | 392 | 0.030 |
Why?
| Tumor Burden | 1 | 2013 | 142 | 0.030 |
Why?
| Logistic Models | 1 | 2016 | 995 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2016 | 1089 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 2014 | 98 | 0.030 |
Why?
| United States | 2 | 2014 | 5217 | 0.030 |
Why?
| Transplantation, Autologous | 1 | 2014 | 476 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2013 | 291 | 0.030 |
Why?
| Cesarean Section | 1 | 2013 | 179 | 0.030 |
Why?
| Expectorants | 1 | 2011 | 14 | 0.030 |
Why?
| Gestational Age | 1 | 2013 | 435 | 0.030 |
Why?
| Antidotes | 1 | 2011 | 33 | 0.030 |
Why?
| Neoplasms, Plasma Cell | 1 | 2012 | 39 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2012 | 60 | 0.030 |
Why?
| Myocardial Contraction | 1 | 2012 | 116 | 0.030 |
Why?
| Patient Selection | 1 | 2013 | 286 | 0.030 |
Why?
| Patient Care Team | 1 | 2013 | 273 | 0.030 |
Why?
| Cohort Studies | 1 | 2016 | 1543 | 0.030 |
Why?
| Statistics as Topic | 1 | 2011 | 103 | 0.030 |
Why?
| Stroke Volume | 1 | 2012 | 150 | 0.020 |
Why?
| Risk Assessment | 1 | 2016 | 1361 | 0.020 |
Why?
| Recovery of Function | 1 | 2012 | 222 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2017 | 847 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 596 | 0.020 |
Why?
| Analgesics, Non-Narcotic | 1 | 2011 | 140 | 0.020 |
Why?
| Electrocardiography | 1 | 2012 | 290 | 0.020 |
Why?
| Smoking | 1 | 2013 | 556 | 0.020 |
Why?
| Pregnancy | 1 | 2013 | 2620 | 0.020 |
Why?
| Mice | 1 | 2011 | 6413 | 0.010 |
Why?
| Animals | 1 | 2011 | 14385 | 0.010 |
Why?
|
|
Pandey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|